FDA Status
ApprovedA synthetic antioxidant closely related to BHA, used to prevent oxidation in fats and oils. Widely used in food packaging materials.
Concerns
- •endocrine disruption observed at high doses in animal studies
- •liver and kidney effects in rodents
- •may promote or inhibit tumors depending on study conditions
CAERS Adverse Events
No adverse event reports found.
CAERS data is voluntary. Reports indicate correlation, not causation. About CAERS
International Status
European Union
restrictedCanada
approvedCommonly Found In
cerealschewing gumsnack foodsfood packagingbutterdehydrated potatoes
Find products containing BHT
Search 2.8M+ products in our database.